Other and unspecified postprocedural disorders of eye and adnexa

H7_POSTOPEYENAS

eye disease: A non-neoplastic or neoplastic disorder that affects the eye. Representative examples include conjunctivitis, glaucoma, cataract, conjunctival squamous cell carcinoma, uveal melanoma, and retinoblastoma. [NCIt:C26767]

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — H59.8, H59.9 Cause of death: ICD-10 — H59.8, H59.9 2 out of 7 registries used, show all original rules.	65
4. Check minimum number of events None	65
5. Include endpoints None	65
6. Filter based on genotype QC (FinnGen only)	65

Control definitions (FinnGen only)

Control exclude: H7_EYEPOSTOP

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2

NAME	H7_POSTOPEYENAS
CONTROL_EXCLUDE	H7_EYEPOSTOP
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	H59[8-9]
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	H59[8-9]
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Other and unspecified postprocedural disorders of eye and adnexa based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	541	282	257
Only index persons	456	238	218
Unadjusted period prevalence (%)
Whole population	0.01	0.01	0.01
Only index persons	0.01	0.01	0.01
Median age at first event (years)
Whole population	71.21	72.30	70.00
Only index persons	69.97	70.56	69.33

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	65	38	27
Unadjusted period prevalence (%)	0.01	0.01	0.01
Median age at first event (years)	71.54	71.86	71.09

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
53: Matched controls
530

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

H59.9

ICD-10 Finland

Postprocedural disorder of eye and adnexa, unspecified

+∞

34.1

H59.8

ICD-10 Finland

Other postprocedural disorders of eye and adnexa

+∞

27.5

Z96.1

ICD-10 Finland

Presence of intraocular lens

11.6

14.1

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

9.3

12.5

131

CKD60

NOMESCO Finland

Anterior vitrectomy

37.8

9.9

CHB10

NOMESCO Finland

Puncture of anterior chamber of eye with irrigation

40.2

8.4

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

5.7

8.3

127

CKD94

NOMESCO Finland

Combined vitrectomy and procedure on lens through pars plana

22.6

8.0

WX140

NOMESCO Finland

Parabulbar anesthesy

13.9

7.8

WX100

NOMESCO Finland

Conjunctival surface anesthesia

7.0

7.6

CKD65

NOMESCO Finland

Pars plana or pars plicata vitrectomy

24.1

7.4

H33.0

ICD-10 Finland

Retinal detachment with retinal break

13.7

7.2

S01ED51

ATC

timolol, combinations; ophthalmic

10.1

7.2

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3019225) pH of Specimen

5.98

9.11

3.4

3.6

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

4.22

6.26

4.2

5.6

30.64

31.86

0.19

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

5.73

4.95

1.4

1.7

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

247

2.61

3.43

4.8

5.6

1.24

1.21

mmol/l

2.22

223

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

280

2.58

3.23

4.9

6.0

1.24

1.21

mmol/l

2.17

226

(3013512) EKG study

169

2.44

3.03

4.6

4.3

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

4.57

3.01

1.3

1.6

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

121

2.24

1.8

2.1

—

(1761868) Lipid panel - Serum or Plasma

172

0.39

1.97

3.8

3.5

—

(3002030) Lymphocytes/100 leukocytes in Blood

240

1.99

1.96

4.1

6.0

25.07

26.05

0.16

223

(36660697) Celiac disease serology panel - Serum

2.91

1.95

1.0

1.1

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

321

2.00

1.84

2.3

2.8

56.94

54.10

u/l

0.04

293

(3044640) Blood type and Crossmatch panel - Blood

174

1.94

1.76

1.7

2.2

—

(3022313) Gas panel - Capillary blood

3.37

1.70

2.8

2.5

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

250

1.87

1.65

2.9

3.8

—

(3001604) Monocytes [#/volume] in Blood

253

1.83

1.56

4.0

5.5

0.65

0.61

e9/l

0.65

224

(3013115) Eosinophils [#/volume] in Blood

263

1.83

1.55

4.1

5.7

0.15

0.19

e9/l

1.26

236

(42870588) Differential panel, method unspecified - Blood

181

1.84

1.53

3.3

5.3

—

(3006315) Basophils [#/volume] in Blood

255

1.81

1.51

4.1

5.6

0.04

e9/l

0.02

226

(3009343) pH of Capillary blood

2.58

1.43

2.6

2.5

—

7.45

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

2.58

1.43

3.6

6.5

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1.98

1.41

1.6

1.8

—

(40758558) Short blood count panel - Blood

154

0.45

1.37

5.4

7.1

—

(3019198) Lymphocytes [#/volume] in Blood

261

1.74

1.35

4.1

5.5

1.83

1.77

e9/l

0.13

237

(3022621) pH of Urine by Test strip

2.26

1.23

3.3

2.8

—

(3013707) Erythrocyte sedimentation rate by Westergren method

398

1.79

1.21

4.4

12.47

12.99

mm/h

0.11

353

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

515

2.17

1.15

12.7

16.6

21.71

24.16

mg/l

0.27

423

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

241

1.65

1.13

2.1

2.0

75.14

97.20

pmol/l

1.64

109

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

2.33

1.12

1.3

1.6

—

(40761511) CBC panel - Blood by Automated count

531

2.20

1.07

13.5

16.0

—

(21494755) Public health laboratory ask at order entry panel

0.00

1.00

0.0

1.5

—

(3021589) Normoblasts [#/volume] in Blood

241

0.60

0.97

5.5

11.7

0.00

e9/l

—

206

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

478

1.77

0.90

5.0

4.7

2.11

1.98

mu/l

0.36

420

(3012516) Albumin [Mass/volume] in Urine

160

1.57

0.86

4.5

3.0

74.00

80.88

mg/l

0.04

(3019060) Gas panel - Arterial blood

1.80

0.84

1.5

2.8

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

141

0.58

0.82

1.4

1.7

0.85

1.29

mmol/l

—

115

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1.74

0.82

4.5

7.6

—

(3020891) Body temperature

0.00

0.81

0.0

3.7

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

222

0.63

0.81

2.7

4.4

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

306

1.49

0.78

5.2

10.2

4.69

4.54

e9/l

0.11

276

(3009542) Hematocrit [Volume Fraction] of Blood

444

1.55

0.71

13.7

18.0

38.48

39.68

0.23

287

(3013139) Helicobacter pylori Ag [Presence] in Stool

1.78

0.65

1.0

1.2

—

(3001019) Free T4 and TSH panel - Serum or Plasma

0.00

0.61

0.0

1.8

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

0.00

0.61

0.0

2.2

—

0.30

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

0.00

0.61

0.0

1.4

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

248

1.39

0.59

3.7

3.9

51.15

55.44

ng/l

0.06

180

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1.64

0.56

1.0

1.4

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

485

1.50

0.55

13.1

16.1

72.15

76.07

ml/min/173m2

0.57

398

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

496

1.52

0.55

5.0

5.2

5.95

6.03

mmol/l

0.20

444

(3007853) Bacteria identified in Skin by Aerobe culture

1.50

0.55

1.4

1.6

—

(3037522) Nuclear Ab [Titer] in Serum

1.50

0.55

1.2

1.3

—

292.50

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1.47

0.54

1.6

1.8

—

(3020682) Albumin/Creatinine [Ratio] in Urine

175

1.39

0.53

4.7

3.8

25.20

11.60

mg/mmol

0.27

105

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

523

1.51

0.49

4.5

5.4

2.66

2.60

mmol/l

0.17

467

(40761535) Cells panel - Urine sediment

1.48

0.48

3.1

3.4

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

197

1.35

0.47

2.1

3.7

2.42

2.35

mmol/l

2.13

164

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

395

1.35

0.47

3.5

3.7

15.72

14.98

pmol/l

1.05

342

(3041096) Erythrocytes [Presence] in Urine by Automated

160

0.69

0.47

2.6

4.1

—

(3026008) Bacteria identified in Urine by Culture

181

0.71

0.46

3.6

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

480

1.42

0.46

3.8

4.3

1.20

1.23

mmol/l

0.12

428

(3021960) Folate [Moles/volume] in Serum or Plasma

151

1.36

0.45

1.8

1.5

20.15

23.10

nmol/l

0.29

123

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

0.00

0.42

0.0

1.5

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

0.00

0.42

0.0

1.7

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

0.00

0.42

0.0

1.7

—

(40767503) Oxygen content in Capillary blood by calculation

0.00

0.41

0.0

3.2

—

16.00

—

(3012501) Base excess in Blood by calculation

0.00

0.41

0.0

4.6

—

2.10

—

(3013290) Carbon dioxide [Partial pressure] in Blood

0.00

0.41

0.0

4.6

—

5.08

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

0.00

0.41

0.0

1.3

—

(3027315) Oxygen [Partial pressure] in Blood

0.00

0.41

0.0

4.6

—

7.84

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

0.00

0.40

0.0

2.8

—

56.89

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

0.00

0.40

0.0

2.3

—

125.50

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1.39

0.32

1.2

1.5

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

543

1.40

0.32

16.9

19.1

80.93

80.63

umol/l

0.03

543

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

500

1.32

0.31

4.3

4.9

4.58

4.51

mmol/l

0.19

453

(36304419) Bacteria [Presence] in Urine

150

0.75

0.31

3.4

3.2

—

(3023368) Bacteria identified in Blood by Culture

151

1.27

0.29

2.4

4.8

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1.26

0.28

1.5

1.8

—

(3044889) 12 lead EKG panel

372

0.82

0.28

2.9

4.4

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

201

1.22

0.26

2.6

3.2

1541.61

1781.10

ng/l

0.13

166

(40768797) Stomach Pathology biopsy report

0.72

0.26

1.3

1.2

—

(3019832) Treponema pallidum Ab [Presence] in Serum

1.38

0.24

1.4

1.7

—

(40768804) Tissue Pathology biopsy report

217

0.82

0.23

2.5

2.1

—

(3018095) Leukocytes [#/volume] in Urine

196

0.82

0.22

3.6

4.1

13.19

69.28

e6/l

2.41

144

(4010399)

1.24

0.22

2.2

1.4

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

0.00

0.21

0.0

1.0

—

(3022806) Fractional oxyhemoglobin in Capillary blood

0.00

0.21

0.0

2.7

—

88.45

—

(3024928) Oxygen saturation in Venous blood

0.00

0.21

0.0

2.9

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

0.00

0.21

0.0

1.1

—

(3028271) Lactate [Moles/volume] in Capillary blood

0.00

0.21

0.0

2.6

—

1.34

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

0.00

0.21

0.0

1.3

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

0.00

0.20

0.0

1.4

—

295.76

—

(1616796) Gas panel - Central venous blood

0.00

0.20

0.0

3.9

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

498

1.22

0.19

4.5

4.9

1.57

1.48

mmol/l

0.66

446

(3003694) ABO and Rh group [Type] in Blood

131

0.81

0.19

1.4

—

(3012544) pH of Venous blood

1.26

0.19

2.3

3.3

—

(3002256) Pathology report gross observation

1.23

0.19

1.0

1.2

—

(3000494) Fungus identified in Specimen by Culture

1.14

0.18

1.0

1.5

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1.14

0.17

4.5

4.6

1.13

1.05

mmol/l

—

(3042936) Bacteria identified in Isolate by Culture

0.76

0.15

1.3

2.3

—

(3037467) Urinalysis macro (dipstick) panel - Urine

371

1.13

0.13

5.9

4.9

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

493

1.16

0.13

6.5

6.6

39.26

40.91

mmol/mol

0.78

450

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1.05

0.09

1.0

2.1

0.23

0.21

g/l

—

(40760892) CBC W Ordered Manual Differential panel - Blood

113

0.86

0.09

3.6

4.6

—

(3022145) Colonoscopy Study observation

0.82

0.08

1.0

1.3

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

178

1.10

0.06

4.7

5.2

1.82

1.99

ug/l

0.07

154

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

268

1.08

0.06

2.8

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

201

0.92

0.05

3.7

3.4

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

120

0.90

0.05

3.0

3.8

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

143

1.06

0.02

4.3

4.4

21.53

22.17

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

0.00

0.0

1.2

—

(3045142) Bone marrow Pathology biopsy report

0.00

0.0

1.2

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

0.00

0.0

2.8

—

30.17

—

(3004616) Nuclear Ab [Presence] in Serum

0.00

0.0

1.0

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

0.00

0.0

1.2

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

0.00

0.0

1.2

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

0.00

0.0

1.2

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

0.00

0.0

1.0

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

0.00

0.0

1.8

—

0.85

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

0.00

0.0

1.3

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

0.00

0.0

2.1

—

(3044242) Glucose [Moles/volume] in Arterial blood

0.00

0.0

2.4

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

0.00

0.0

3.4

—

(3038026) Centromere Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

0.00

0.0

1.2

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

0.00

0.0

1.3

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.3

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

0.00

0.0

1.1

—

(3032773) Endomysium IgG Ab [Titer] in Serum

0.00

0.0

1.0

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

0.00

0.0

1.0

—

(21494434) Karyotype in Bone marrow

0.00

0.0

1.0

—

(3023410) Appearance of Cerebral spinal fluid

0.00

0.0

1.4

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.0

1.0

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.0

1.0

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

0.00

0.0

1.0

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

0.00

0.0

3.4

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

0.00

0.0

1.0

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

0.00

0.0

1.2

—

(3002523) Influenza virus A Ag [Presence] in Specimen

0.00

0.0

1.2

—

(3004451) EKG impression Narrative

0.00

0.0

1.4

—

(1617658) Protocol used for examination of sentinel lymph nodes

0.00

0.0

1.0

—

(3044927) Protein electrophoresis panel - Urine

0.00

0.0

1.2

—

(3003740) Influenza virus B Ag [Presence] in Specimen

0.00

0.0

1.2

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

0.00

0.0

4.0

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

0.00

0.0

1.6

—

4.93

—

(3017569) Oxygen content in Arterial blood

0.00

0.0

2.6

—

(40768795) Lymph node Pathology biopsy report

0.00

0.0

1.1

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

0.00

0.0

1.6

—

60.14

—

(3039443) Prostate specific Ag panel - Serum or Plasma

0.00

0.0

1.7

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

0.96

0.00

1.6

1.4

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

0.00

0.0

1.1

—

(40768441) Liver Pathology biopsy report

0.00

0.0

1.0

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

0.00

0.0

1.4

—

(3029075) Extractable nuclear Ab panel - Serum

0.00

0.0

1.0

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

0.00

0.0

1.0

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.7

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

0.00

0.0

1.0

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.0

1.0

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

0.00

0.0

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.0

1.0

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

0.00

0.0

1.3

—

(3023420) DNA double strand Ab [Units/volume] in Serum

0.00

0.0

1.8

—

(3025130) Human papilloma virus identified in Specimen

0.00

0.0

2.2

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

0.00

0.0

1.0

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

0.00

0.0

1.8

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.0

1.0

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

0.00

0.0

3.0

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

0.00

0.0

1.1

—

(4281824)

0.00

0.0

1.0

—

(40768800) Prostate Pathology biopsy report

0.00

0.0

1.4

—

(4268621)

0.00

0.0

1.6

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

0.00

0.0

1.6

—

2.80

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

0.00

0.0

3.0

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

0.00

0.0

1.1

—

Mortality – FinRegistry

↥

Association

Association between endpoint H7_POSTOPEYENAS and mortality.

Females

Parameter	HR [95% CI]	p-value
H7_POSTOPEYENAS	1.186 [0.87, 1.61]	0.277
Birth year	0.998 [0.99, 1.01]	0.592

During the follow-up period (1.1.1998 — 31.12.2019), 77 out of 221 females with H7_POSTOPEYENAS died.

Males

Parameter	HR [95% CI]	p-value
H7_POSTOPEYENAS	1.221 [0.89, 1.68]	0.222
Birth year	0.987 [0.98, 1.0]	0.009

During the follow-up period (1.1.1998 — 31.12.2019), 87 out of 207 males with H7_POSTOPEYENAS died.

Mortality risk

Mortality risk for people of age

years, who have H7_POSTOPEYENAS.

N-year risk	Females	Males
1	0.158%	0.267%
5	0.729%	1.541%
10	1.938%	3.612%
15	3.787%	6.642%
20	6.666%	11.455%

Relationships between endpoints

↥

Index endpoint: H7_POSTOPEYENAS – Other and unspecified postprocedural disorders of eye and adnexa

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Other and unspecified postprocedural disorders of eye and adnexa

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints